Fecal transplant for chronic bowel inflammation in CGD
Part of Immune system & allergy clinical trials.
This study tests whether transplanting stool microbiome (fecal microbiota transplant) can improve chronic colitis in people with chronic granulomatous disease (CGD). It aims to reduce bowel inflammation and symptoms by changing gut bacteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 10 and 60 years old
- You (or your parent/guardian) can sign consent
- You have confirmed CGD and CGD-related bowel inflammation (colitis), shown by past diagnosis and tests/colonoscopy
- Your stool inflammation marker (fecal calprotectin) is at least 200 microgram/g
- Your bowel symptom score (HBI) is at least 5 on the first study day
- Your CGD bowel treatment and antibiotics have been stable with no planned change for about 1 month before the transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether transferring healthy gut bacteria (a fecal microbiome transplant) can help children with repeated or moderate-to-severe C. difficile infection. It focuses on changing gut bacteria to reduce ongoing infection and symptoms.
This Phase 1/2 study tests whether a fecal microbiome transplant (FMT) can reduce active inflammation in people with Crohn’s disease. It’s designed for people who currently have signs of active bowel inflammation and can attend regular procedure visits.
This study tests whether transplanting healthy donor stool into the gut can help children and young adults with ongoing digestive issues after a stem cell transplant. It may improve symptoms like diarrhea or the need for feeding tubes.
This trial tests whether a stool transplant (fecal microbiota transplantation) can help manage active ulcerative colitis. You would receive a transplant from a healthy donor to see if it improves your symptoms.
This study tests if a fecal transplant (transferring healthy bacteria from a donor's stool into your gut) can help people with severe gut graft-versus-host disease that hasn't responded to steroids. It's for patients who have had a stem cell transplant and now have ongoing, severe gut symptoms.
This trial tests whether transferring stool microbes (called fecal microbiota transplantation, or FMT) can improve Crohn’s disease in children who have not gotten better with usual treatments. If you qualify, the study will check symptoms and colon imaging/score changes over the study follow-up.
Hear when a new Chronic Granulomatous Disease-associated Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.